HCA Healthcare, Inc. Q2 2026 Earnings Recap

HCA Healthcare’s stock rose modestly by 1.5% as volume growth and Medicaid supplemental payments partly offset financial pressure from a significant payer mix shift driven by a surge in uninsured patients after the expiration of enhanced premium tax credits.

Key Takeaways

• Adjusted admissions declined sharply by 15% for patients formerly covered by health insurance exchanges, with most migrating nearly 1-for-1 to uninsured status.
• Three domestic divisions accounted for roughly half of the negative payer mix impact, weighing on overall financial performance.
• Insured patient volumes excluding exchanges increased by 3.2% in the quarter, supported by growth in ER visits (+3.6%) and emergency inpatient surgeries; however, inpatient and outpatient elective surgeries declined (~2.3% and ~3.4% respectively).
• Net revenue per equivalent admission grew 6.4%, boosted by Medicaid supplemental payments (notably in Florida), rate increases, and governmental payment updates that helped offset mix-related rate pressures.
• The company affirmed ongoing investments with $7 billion in capital expenditures approved and emphasized operational efficiencies from its financial resiliency program to mitigate cost pressures.